Skip to main content

Table 1 Frequency of drugs administered to JDM patients in EU and LA centers

From: Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America

 

Oral/iv steroids

Pulse iv steroids

MTX

CyA

Iv Ig

AM

AZA

Oral CPM

Pulse iv CPM

EU (N = 246)

97.6

50

50.8

35

17.1

26

13.4

5.3

8.5

LA (N = 236)

99.6

33.2

61.4

15.7

17.4

39

5.9

2.1

4.2

  1. MTX: methotrexate; CyA: cyclosporine A; AM: antimalarials; AZA: azathioprine; CPM: cyclophosphamide